Literature DB >> 15330009

Mast cells and mast cell mediators as targets of dietary supplements.

Theoharis C Theoharides1, Leonard Bielory.   

Abstract

OBJECTIVE: To review the increasing amount of data that support or dispel the use of dietary supplements in the treatment of inflammatory conditions that involve mast cells, such as allergies, arthritis, and chronic pelvic pain syndrome. DATA SOURCES: A search was conducted in MEDLINE for natural substances, dietary supplements, flavonoids, and proteoglycans for their in vitro or in vivo effects on allergic and inflammatory conditions. STUDY SELECTION: Studies were selected for inclusion because of the impact factor of the journal, the definitive nature of the findings, the soundness of the study design, and the expert opinion of the authors.
RESULTS: Dietary supplements include a large group of products, such as vitamins, minerals, plant, or animal extracts, as well as herbal preparations that are often called medicinal herbs. Many of the available dietary supplements contain a multitude of ingredients, the source and/or purity of which is seldom disclosed; some of these may have biologic effects of their own or may interact with other supplements or drugs, often leading to adverse effects. The most well-documented evidence published to date is on the inhibitory action of natural compounds, especially flavonoids, on mast cells and allergic symptoms. Some flavonoids have weak inhibitory activity, whereas others may have no benefit or may be detrimental. Sulfated proteoglycans could provide synergistic action but require formulations with increased absorption.
CONCLUSIONS: Combining the most active flavonoids with proteoglycans could be helpful in atopic and inflammatory conditions. However, a complete list of active ingredients and their source, purity, and exact concentration should be a requirement for nutraceuticals to standardize, compare, and promote their safe use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330009     DOI: 10.1016/s1081-1206(10)61484-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

1.  Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment.

Authors:  Lan-Xiang Wu; Cheng-Xian Guo; Wang-Qing Chen; Jing Yu; Qiang Qu; Yao Chen; Zhi-Rong Tan; Guo Wang; Lan Fan; Qing Li; Wei Zhang; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Moxibustion activates mast cell degranulation at the ST25 in rats with colitis.

Authors:  Yin Shi; Li Qi; Jing Wang; Ming-Shu Xu; Dan Zhang; Lu-Yi Wu; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 3.  Neuroimmunology of stress: skin takes center stage.

Authors:  Petra C Arck; Andrzej Slominski; Theoharis C Theoharides; Eva M J Peters; Ralf Paus
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

4.  Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo.

Authors:  Pu Hu; Ming Wang; Wei-Heng Chen; Ji Liu; Liang Chen; Shu-Ting Yin; Wu Yong; Ju-Tao Chen; Hui-Li Wang; Di-Yun Ruan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

Review 5.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 7.  Antioxidant enrichment and antimicrobial protection of fresh-cut fruits using their own byproducts: looking for integral exploitation.

Authors:  J F Ayala-Zavala; C Rosas-Domínguez; V Vega-Vega; G A González-Aguilar
Journal:  J Food Sci       Date:  2010-09-23       Impact factor: 3.167

8.  Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus.

Authors:  Ji-Hye Kim; Min-Jung Kang; Ha-Neul Choi; Soo-Mi Jeong; Young-Min Lee; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2011-04-23       Impact factor: 1.926

9.  Pathophysiology of the Behçet's Disease.

Authors:  Umit Türsen
Journal:  Patholog Res Int       Date:  2011-10-01

10.  Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial.

Authors:  Jonathan Corren; Marc Lemay; Yumei Lin; Lisa Rozga; R Keith Randolph
Journal:  Nutr J       Date:  2008-07-14       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.